| Attribute |
Typical rSV40 characteristics |
| Titer |
Typically, 1011 to 1012 infectious particles/mL
|
| Longevity of transgene expression |
Once established, transgene expression persists indefinitely. |
| Gene delivery efficiency |
In vitro: Usually >98%, without selection |
|
In vivo: In discrete organs (e.g., liver), >90% of cells can be transduced. |
| Maximum insert size |
Up to 5 kb |
| Target cell tropisms |
Almost all resting and dividing cells can be transduced. |
| Antigenicity imparted to target cells |
None observed to date |
| Neutralizing antibody |
None observed to date |
| “Gutless” vectors |
Generated exactly as nongutless vectors. Yields are comparable to those of nongutless vectors. |
| Hardiness |
Very robust; in lyophilized form, can be stored for long periods of time at 4°C and even at room temperature. |
| Promoters used |
Constitutive pol II, pol III promoters; conditional pol III promoters |
| Transgenes expressed |
Almost all mammalian cDNAs; cDNAs of mammalian viruses |
| Limitations |
Nonvertebrate marker genes generally not expressed (e.g., GFP and β-galactosidase) |
|
Levels of protein expression are generally lower than seen with many other vector systems. |